Printing composite nanofilaments for use in a simple and low-cost 3D pen
Source abstract
Abstract
In this work, filament based on ɛ-polycaprolactone (PCL) and containing the bioactive ceramics nanohydroxyapatite (nHap) and Laponite® (Lap) was prepared by the extrusion process. To obtain the material, a mass ratio of 89:10:1 (PCL:nHap:Lap) was used, and structural and morphological characterization was realized. In addition, cytotoxicity (usingAllium cepabulbs) and viability tests on L929 cells also were performed. The results showed that filament (diameter of 1.79 ± 0.17 mm) presented a good dispersion of nHap and Lap into polymeric matrices. Fourier transform infrared spectroscopy identified typical bands at 1720, 1091, and 1045 cm−1addressed to PCL and nHAp, In addition, Lap was identified through dispersive energy system and X-ray diffraction analyses. All filaments did not exhibit cytotoxic effects.
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Additive Manufacturing and 3D Printing Technologies · 3D Printing in Biomedical Research · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (69)
Show source-provided references
1. 10.1016/j.fct.2018.12.03710.1016/j.fct.2018.12.037 ↗
2. 64. International Organization for Standardization. ISO 10993-5. In: Biological Evaluation of Medical Devices-Part 5: Tests for In Vitro Cytotoxicity . Geneve: ISO; 2009.
3. 10.1016/j.clay.2013.08.04910.1016/j.clay.2013.08.049 ↗
4. 10.1016/j.compositesb.2018.09.06510.1016/j.compositesb.2018.09.065 ↗
5. 10.1016/j.jmbbm.2017.12.02910.1016/j.jmbbm.2017.12.029 ↗
6. 10.1016/j.matdes.2018.11.05410.1016/j.matdes.2018.11.054 ↗
7. 10.3390/bioengineering503005410.3390/bioengineering5030054 ↗
8. 10.1007/s10973-018-7155-510.1007/s10973-018-7155-5 ↗
9. 10.1016/j.colsurfb.2017.12.04310.1016/j.colsurfb.2017.12.043 ↗
10. 10.1016/j.bioactmat.2018.12.00310.1016/j.bioactmat.2018.12.003 ↗
11. 10.5618/bio.2012.v2.n1.410.5618/bio.2012.v2.n1.4 ↗
12. 10.1111/j.1601-5223.1985.tb00471.x10.1111/j.1601-5223.1985.tb00471.x ↗
13. 10.1002/adhm.20190015810.1002/adhm.201900158 ↗
14. 10.1107/S056774087000519810.1107/S0567740870005198 ↗
15. 10.1016/j.jddst.2017.04.01210.1016/j.jddst.2017.04.012 ↗
16. 10.1016/j.clay.2011.04.00710.1016/j.clay.2011.04.007 ↗
17. 10.1016/j.jcis.2006.07.01010.1016/j.jcis.2006.07.010 ↗
18. 10.1590/S1516-1439200700010000910.1590/S1516-14392007000100009 ↗
19. 10.1016/j.biomaterials.2010.07.10910.1016/j.biomaterials.2010.07.109 ↗
20. 10.1016/j.polymdegradstab.2009.11.02310.1016/j.polymdegradstab.2009.11.023 ↗
21. 10.1016/j.nano.2017.04.01610.1016/j.nano.2017.04.016 ↗
22. 10.1016/j.cossms.2017.08.00210.1016/j.cossms.2017.08.002 ↗
23. 10.1016/j.biomaterials.2008.10.06510.1016/j.biomaterials.2008.10.065 ↗
24. 10.1016/j.ijpharm.2018.01.03610.1016/j.ijpharm.2018.01.036 ↗
25. Preparation of laponite bioceramics for potential bone tissue engineering applications
26. 10.1016/j.msec.2018.12.03310.1016/j.msec.2018.12.033 ↗
27. 10.1016/j.eurpolymj.2019.02.00610.1016/j.eurpolymj.2019.02.006 ↗
28. 10.1016/j.ijbiomac.2018.11.21410.1016/j.ijbiomac.2018.11.214 ↗
29. 10.1002/adma.20130058410.1002/adma.201300584 ↗
30. 10.1590/0366-6913201965373244110.1590/0366-69132019653732441 ↗
31. 10.1016/j.msec.2019.01.06310.1016/j.msec.2019.01.063 ↗
32. 10.1016/j.msec.2018.12.02710.1016/j.msec.2018.12.027 ↗
33. 10.1016/j.clay.2018.12.00310.1016/j.clay.2018.12.003 ↗
34. 10.1631/jzus.B160011810.1631/jzus.B1600118 ↗
35. 10.1016/j.colsurfb.2016.03.03310.1016/j.colsurfb.2016.03.033 ↗
36. Fabrication process of polymer nano-composite filament for fused deposition modeling
37. 10.1134/S002016851801017X10.1134/S002016851801017X ↗
38. 10.1016/j.measurement.2016.03.06110.1016/j.measurement.2016.03.061 ↗
39. 10.1126/science.122634010.1126/science.1226340 ↗
40. 10.1016/j.jes.2017.05.01210.1016/j.jes.2017.05.012 ↗
41. 10.1016/j.colsurfb.2015.06.07410.1016/j.colsurfb.2015.06.074 ↗
42. 10.1016/j.eurpolymj.2018.05.03410.1016/j.eurpolymj.2018.05.034 ↗
43. 10.1016/j.carbpol.2016.08.03710.1016/j.carbpol.2016.08.037 ↗
44. 10.1016/j.jdent.2018.11.00410.1016/j.jdent.2018.11.004 ↗
45. 10.1016/j.actbio.2018.12.03810.1016/j.actbio.2018.12.038 ↗
46. 10.1016/j.jmbbm.2019.01.02010.1016/j.jmbbm.2019.01.020 ↗
47. Polymer composites for tribological applications
48. 10.1016/j.matdes.2018.11.01810.1016/j.matdes.2018.11.018 ↗
49. PCL and PCL-based materials in biomedical applications
50. 10.1016/j.jeurceramsoc.2018.11.01310.1016/j.jeurceramsoc.2018.11.013 ↗
51. 10.1016/j.actbio.2018.10.02310.1016/j.actbio.2018.10.023 ↗
52. Preparation of laponite bioceramics for potential bone tissue engineering applications
53. The feasibility of printing polylactic acid—Nanohydroxyapatite composites using a low-cost fused deposition modeling 3D printer
54. 10.1016/j.ijpharm.2017.04.07710.1016/j.ijpharm.2017.04.077 ↗
55. 10.1016/j.msec.2018.12.00510.1016/j.msec.2018.12.005 ↗
56. 10.1590/1980-5373-mr-2016-111210.1590/1980-5373-mr-2016-1112 ↗
57. 10.1016/j.carbpol.2018.10.03410.1016/j.carbpol.2018.10.034 ↗
58. 10.1016/j.msec.2017.02.08710.1016/j.msec.2017.02.087 ↗
59. 10.1038/s41598-018-19428-510.1038/s41598-018-19428-5 ↗
60. 10.1016/j.eurpolymj.2017.04.01410.1016/j.eurpolymj.2017.04.014 ↗
61. 10.1016/j.apsusc.2018.10.16610.1016/j.apsusc.2018.10.166 ↗
62. 10.1016/j.saa.2016.09.05010.1016/j.saa.2016.09.050 ↗
63. 10.1007/s11581-015-1586-910.1007/s11581-015-1586-9 ↗
64. 10.1016/j.ijbiomac.2019.02.05810.1016/j.ijbiomac.2019.02.058 ↗
65. 10.3390/jcs302004510.3390/jcs3020045 ↗
66. 10.1016/j.scitotenv.2018.12.44410.1016/j.scitotenv.2018.12.444 ↗
67. 10.1155/2016/159615710.1155/2016/1596157 ↗
68. 10.1016/j.ceramint.2018.09.30010.1016/j.ceramint.2018.09.300 ↗
69. 10.1016/j.msec.2013.02.02710.1016/j.msec.2013.02.027 ↗